Rein Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold RNTX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$1061695
Total value held
Buying
7 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | State Street Corp | $394788 | 379604 | +303700 | +400.11% |
| 2 | Blackrock, Inc. | $339253 | 326204 | +257676 | +376.02% |
| 3 | Northern Trust Corp | $166109 | 159720 | +95584 | +149.03% |
| 4 | Goldman Sachs Group Inc | $82976 | 79785 | +79785 | NEW BUY |
| 5 | Ubs Group Ag | $59706 | 57410 | +57410 | NEW BUY |
| 6 | Morgan Stanley | $14890 | 14318 | +14318 | NEW BUY |
| 7 | Barclays Plc | $2673 | 2570 | +2570 | NEW BUY |
| 8 | Us Bancorp \De\ | $1300 | 1250 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.